CYCC

Cyclacel Pharmaceuticals, Inc. Competitors

$3.13
*  
0.05
1.57%
Get CYCC Alerts
*Delayed - data as of Sep. 12, 2014  -  Find a broker to begin trading CYCC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

Cyclacel Pharmaceuticals, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Prana Biotechnology Ltd
PRAN: NASDAQ-CM
$ 2.30 -0.04 ▼ 520,773 $ 2.39
$ 2.29
$ 13.29
$ 1.47
NE 93,869,900
Prestige Brand Holdings, Inc.
PBH: NYSE
$ 33.55 -0.31 ▼ 246,220 $ 33.974
$ 33.44
$ 36.69
$ 24.94
25.61 1,743,627,050
Prima BioMed Ltd
PBMD: NASDAQ-GM
$ 1.03 0.00 ▲ 167,393 $ 1.0899
$ .902
$ 2.40
$ .82
NE 36,601,050
Progenics Pharmaceuticals Inc.
PGNX: NASDAQ-GS
$ 5.27 -0.15 ▼ 616,162 $ 5.43
$ 5.19
$ 7.45
$ 3.1001
NE 366,560,120
ProPhase Labs, Inc.
PRPH: NASDAQ-GM
$ 1.50 -0.06 ▼ 30,321 $ 1.61
$ 1.42
$ 2.98
$ 1.36
NE 28,948,500
Prosensa Holding N.V.
RNA: NASDAQ-GS
$ 8.40 -0.42 ▼ 108,880 $ 8.89
$ 8.32
$ 25.9699
$ 3.431
NE 301,837,200
Prothena Corporation plc
PRTA: NASDAQ-GS
$ 23.38 -0.62 ▼ 234,248 $ 24.31
$ 23.30
$ 49.24
$ 16.71
NE 639,840,460
Provectus Biopharmaceuticals, Inc.
PVCT: AMEX
$ 1.08 0.02 ▲ 459,079 $ 1.10
$ 1.07
$ 3.75
$ .30
NE 190,769,040
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 32.72 -1.14 ▼ 183,308 $ 33.928
$ 32.44
$ 36.165
$ 13.15
NE 984,021,280
Puma Biotechnology Inc
PBYI: NYSE
$ 270.83 -2.85 ▼ 215,384 $ 274.9999
$ 266.45
$ 279.37
$ 33.70
NE 8,156,857,940
QLT Inc.
QLTI: NASDAQ-GS
$ 6.43 -0.14 ▼ 55,758 $ 6.61
$ 6.37
$ 7.10
$ 4.16
NE 328,457,260
Raptor Pharmaceutical Corp.
RPTP: NASDAQ-GM
$ 11.14 -0.31 ▼ 775,738 $ 11.67
$ 10.95
$ 17.72
$ 7.12
NE 697,553,380
Receptos, Inc.
RCPT: NASDAQ-GS
$ 59.67 -0.73 ▼ 598,073 $ 61.03
$ 58.71
$ 61.13
$ 20.90
NE 1,587,878,370
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 3.896 -0.10 ▼ 89,406 $ 4.04
$ 3.79
$ 9.88
$ 2.88
NE 30,030,368
Redhill Biopharma Ltd.
RDHL: NASDAQ-CM
$ 14.30 -0.17 ▼ 4,805 $ 14.39
$ 12.20
$ 21
$ 9.01
NE 125,053,500
Regado BioSciences, Inc.
RGDO: NASDAQ-CM
$ 1.10 unch 410,322 $ 1.15
$ 1.10
$ 14.10
$ 1.01
NE 36,969,900
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 346.06 -4.28 ▼ 573,714 $ 349.83
$ 344.05
$ 369.31
$ 257.69
98.59 34,218,412,800
Regulus Therapeutics Inc.
RGLS: NASDAQ-GM
$ 7.90 -0.13 ▼ 78,699 $ 8.08
$ 7.84
$ 11.88
$ 5.404
NE 342,520,300
Reliv' International, Inc.
RELV: NASDAQ-GS
$ 1.24 -0.01 ▼ 1,681 $ 1.27
$ 1.22
$ 3.50
$ 1.14
41.33 15,705,840
Relypsa, Inc.
RLYP: NASDAQ-GS
$ 25.92 0.62 ▲ 278,951 $ 26.08
$ 25.16
$ 52.74
$ 11.55
NE 877,262,400
Retrophin, Inc.
RTRX: NASDAQ-GM
$ 12.80 -0.16 ▼ 152,032 $ 13.105
$ 12.47
$ 24.25
$ 9.09
NE 341,529,600
Revance Therapeutics, Inc.
RVNC: NASDAQ-GM
$ 21.22 -0.61 ▼ 183,677 $ 21.85
$ 20.76
$ 39.86
$ 21
NE 498,521,460
Rexahn Pharmaceuticals, Inc.
RNN: AMEX
$ .745 0.00 ▲ 789,338 $ .79
$ .74
$ 1.85
$ .37
NE 132,798,485
Rigel Pharmaceuticals, Inc.
RIGL: NASDAQ-GS
$ 2.23 -0.08 ▼ 642,833 $ 2.33
$ 2.20
$ 5
$ 2.12
NE 195,194,130
Rosetta Genomics Ltd.
ROSG: NASDAQ-CM
$ 3.68 -0.03 ▼ 14,067 $ 3.73
$ 3.67
$ 6.69
$ 2.35
NE 9,420,800